Stock info Anika Therapeutics | Filter  Basic-Info

Stock: Anika Therapeutics (US broad)

Last Price 26.95 Max Price 32.10
Min Price 20.46 1 Year return -25.40
Sector Health Care Subsector Biotechnology
Annual report 2016

Loading...

Contact info:Street: 32 Wiggins AvenueZip Code: MA 01730City: BedfordCountry: USAPhone: 781-457-9000Email: AP@anipharmaceuticals.comWebsite: www.anikaeraeuics.comCEO: Dr. Charles H. Sherwood Ph.DCFO: Ms. Sylvia Cheung

Sector Review Anika Therapeutics

Loading...
Year Turnover Total sector Market share
2005 30 22,915 0.13 %
2006 27 26,669 0.10 %
2007 31 29,487 0.10 %
2008 36 33,453 0.11 %
2009 40 49,663 0.08 %
2010 56 53,886 0.10 %
2011 65 59,427 0.11 %
2012 71 66,906 0.11 %
2013 75 73,680 0.10 %
2014 106 96,057 0.11 %
2015 93 110,320 0.08 %
2016 103 117,139 0.09 %
2017 113 121,995 0.09 %
2018 106 130,583 0.08 %
2019 115 141,925 0.08 %
2020 130 170,231 0.08 %

Advice Anika Therapeutics

No Records Found




News Anika Therapeutics

No Records Found

Annual reports Anika Therapeutics

2017 2018 2019 2020 2021

Profile Anika Therapeutics

Anika Therapeutics


The past year was a profitable year Anika Therapeutics investors

Over the period from December 2015 till December 2016 the stock gained around 28 percent. Anika Therapeutics' stock rose the past 5 years at around 433 percent. Anika Therapeutics's revenues between 2011 and 2015 were very volatile through the time and moved between 71,36 million dollars and 93 million dollars. Anika Therapeutics's net incomes between 2011 and 2015 were very volatile through the time and moved between 8,47 million dollars and 30,76 million dollars.

Anika Therapeutics has it' headquarter based in Bedford. Anika Therapeutics is mostly active in the health care eq. & services sector. Dr. Charles H. Sherwood Ph.D leads the company as CEO. The CFO of the company is Ms. Sylvia Cheung. The global health care companies gained around 102 percent over the period 2006-2016. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.

The American company didn't pay out any dividends (in the past 5 years).

Anika Therapeutics financed with relatively a lot of debt

At the end of 2015 the American company's balance sheet was worth 235,75 million dollars. Last year the total debt of the company was 24,9 million dollars. This equals around 10,56 percent of the total balance sheet. The American company's price/earnings-ratio was 20. So the market valued the stock at 20 times the 2015' earnings per share. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the health care company equaled around 564,95 million dollars. At the end of 2015 the American company had around 14,93 million stocks listed.

All Anika Therapeutics's financial reports are available here. More information about Anika Therapeutics can be found it's website. .


Results Anika Therapeutics

Results
2015
2016
2017
2018
2019
2020
Revenue
93
103
113
106
115
130
Costs
62
71
82
87
87
154
Profit
31
33
32
19
27
-24
Margin of profit
33.08
31.49
28.06
17.73
23.72
-18.38
ROI
14.59
14.61
12.08
7.10
9.43
-8.80

Balance Anika Therapeutics

Balance
2015
2016
2017
2018
2019
2020
Equity
211
223
263
264
288
272
Debt
25
17
19
15
42
93
Total assets
236
240
283
279
331
366
Solvency
89.44
92.72
93.23
94.49
87.20
74.51
Cash
138
125
157
159
185
98
Cashflow
40
24
41
35
37
13
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
1.60
1.40
2.13
2.27
0.87
0.14

Details Anika Therapeutics

Details
2016
2017
2018
2019
2020
Price
38.16
48.96
53.91
33.61
51.85
Eps
2.15
2.11
1.27
1.89
-1.69
Price/earnings-ratio
17.75
23.20
42.45
17.78
-15.82
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
15.23
17.94
18.55
20.16
19.01
Market to book
0.40
0.37
0.34
0.60
0.71
Cashflow per stock
1.67
2.78
2.46
2.59
0.91
Stocks
15
15
14
14
14
Market Cap
558.17
719.12
766.06
480.89
383.01

Dividend Anika Therapeutics

Dividend
2015
2016
2017
2018
2019
2020
Dividend
0.0
0.0
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
0.0
0.0

Price info Anika Therapeutics

Date
Price
07 Jun 2023
26.95
06 Jun 2023
26.73
02 Jun 2023
26.72
26 May 2023
26.88
25 May 2023
27.02
24 May 2023
27.03
23 May 2023
26.98
18 May 2023
26.02
15 May 2023
25.16
12 May 2023
25.31
01 May 2023
25.66
29 Apr 2023
25.66
25 Apr 2023
26.69
24 Apr 2023
27.07
22 Apr 2023
27.07
21 Apr 2023
27.23
19 Apr 2023
27.82
18 Apr 2023
28.77
15 Apr 2023
27.72
13 Apr 2023
27.39
12 Apr 2023
27.23
11 Apr 2023
27.68
10 Apr 2023
28.30
06 Apr 2023
28.53
05 Apr 2023
28.32
04 Apr 2023
28.22
03 Apr 2023
28.86
31 Mar 2023
28.72
30 Mar 2023
27.91
29 Mar 2023
28.54